Neuropsychiatric aspects of HIV infection and AIDS
dc.authorscopusid | 6603321948 | |
dc.contributor.author | Yi?it, Enize Arzu | |
dc.date.accessioned | 2024-09-19T15:49:49Z | |
dc.date.available | 2024-09-19T15:49:49Z | |
dc.date.issued | 2004 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Acquired immune deficiency syndrome (AIDS) is a lethal neuromedical disorder associated with infection by viruses of the Retroviridae class know as human immunodeficiency viruses (HIV). Medical and neuropsychiatric sequelae of HIV infection present a spectrum of diagnostic and treatment challenges to mental health clinicians. These sequelae can result in new onset psychiatric conditions in persons with no premorbid history of severe mental illness, and can complicate the clinical picture in persons with a history of severe mental illness prior to HIV infection. HIV enters the centra nervous system soon after infection, and result in clinical manifestations that may range from neurocognitive impairment to dementia. In this article, some of the more common neuropsychiatric manifestations of HIV infection (HIV-related dementia, now onset psychosis, mood disorders, anxiety, delirium) and general treatment strategies are described. | en_US |
dc.identifier.endpage | 56 | en_US |
dc.identifier.issn | 1016-5134 | |
dc.identifier.issue | 5 | en_US |
dc.identifier.scopus | 2-s2.0-2942740840 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 51 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/15431 | |
dc.identifier.volume | 16 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | tr | en_US |
dc.relation.ispartof | SENDROM | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | antiretrovirus agent | en_US |
dc.subject | benzodiazepine derivative | en_US |
dc.subject | carbamazepine | en_US |
dc.subject | chlorpromazine | en_US |
dc.subject | citalopram | en_US |
dc.subject | desipramine | en_US |
dc.subject | diazepam | en_US |
dc.subject | fluoxetine | en_US |
dc.subject | haloperidol | en_US |
dc.subject | lithium | en_US |
dc.subject | lorazepam | en_US |
dc.subject | methylphenidate | en_US |
dc.subject | neuroleptic agent | en_US |
dc.subject | nortriptyline | en_US |
dc.subject | olanzapine | en_US |
dc.subject | paroxetine | en_US |
dc.subject | proteinase inhibitor | en_US |
dc.subject | risperidone | en_US |
dc.subject | serotonin uptake inhibitor | en_US |
dc.subject | sertraline | en_US |
dc.subject | tricyclic antidepressant agent | en_US |
dc.subject | valproic acid | en_US |
dc.subject | venlafaxine | en_US |
dc.subject | zidovudine | en_US |
dc.subject | acquired immune deficiency syndrome | en_US |
dc.subject | anxiety disorder | en_US |
dc.subject | central nervous system | en_US |
dc.subject | clinical feature | en_US |
dc.subject | cognitive defect | en_US |
dc.subject | delirium | en_US |
dc.subject | dementia | en_US |
dc.subject | disease association | en_US |
dc.subject | disease severity | en_US |
dc.subject | extrapyramidal symptom | en_US |
dc.subject | human | en_US |
dc.subject | Human immunodeficiency virus infection | en_US |
dc.subject | lethality | en_US |
dc.subject | major depression | en_US |
dc.subject | mental health | en_US |
dc.subject | mood disorder | en_US |
dc.subject | neuropsychiatry | en_US |
dc.subject | psychosis | en_US |
dc.subject | psychotherapy | en_US |
dc.subject | Retrovirus | en_US |
dc.subject | review | en_US |
dc.title | Neuropsychiatric aspects of HIV infection and AIDS | en_US |
dc.title.alternative | HIV infeksiyonu ve AIDS'in nöropsikiyatrik yönleri | en_US |
dc.type | Review Article | en_US |